Cargando…

Understanding Hyperlactatemia in Sepsis: Are We There Yet?

Detalles Bibliográficos
Autores principales:	Nalos, Marek, Robergs, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794111/ https://www.ncbi.nlm.nih.gov/pubmed/31206309 http://dx.doi.org/10.1164/rccm.201905-0962LE

Ejemplares similares

Understanding Hyperlactatemia in Human Sepsis: Are We Making Progress?
por: De Backer, Daniel, et al.
Publicado: (2019)

Balanced Crystalloids in Sepsis: Are We There Yet?
por: Hammond, Drayton A., et al.
Publicado: (2020)

Sepsis-associated hyperlactatemia
por: Garcia-Alvarez, Mercedes, et al.
Publicado: (2014)

Dalbavancin for Staphylococcus aureus Bacteremia: Are We There Yet?
por: Mahatanan, Rattanaporn, et al.
Publicado: (2023)

The riddle of hyperlactatemia
por: Gutierrez, Guillermo, et al.
Publicado: (2009)

Future without delirium: not quite there yet but we can start by prescribing touch
por: Fernandes, Susana M., et al.
Publicado: (2022)

The Computational Acid–Base Chemistry of Hepatic Ketoacidosis
por: Torrens, Samuel L., et al.
Publicado: (2023)

We do not need a third mechanistic descriptor for chronic pain states! Not yet
por: Granan, Lars-Petter
Publicado: (2017)

Should we abandon the patient-specific instrumentation ship in total knee arthroplasty? Not quite yet!
por: Török, László, et al.
Publicado: (2021)

Deconstructing Hyperlactatemia in Sepsis Using Central Venous Oxygen Saturation and Base Deficit
por: Semler, Matthew W., et al.
Publicado: (2019)

Transcriptional reprogramming of metabolic pathways in critically ill patients
por: Nalos, Marek, et al.
Publicado: (2016)

Relative Hyperlactatemia in the Emergency Department
por: Bou Chebl, Ralphe, et al.
Publicado: (2020)

Is hyperlactatemia a useful screening marker of severe sepsis in hemato-oncologic malignant patients?
por: Park, S, et al.
Publicado: (2015)

Are payors ready for transparent prices yet?
por: Barman-Aksözen, Jasmin
Publicado: (2022)

Are we there yet?
por: Swann, Nicole
Publicado: (2019)

Are we there yet?
por: Wise, Jo Ann
Publicado: (2015)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?
por: Ariyawutyakorn, Witthawat, et al.
Publicado: (2016)

ARe we there yet? Understanding androgen receptor signaling in breast cancer
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)

Commentary: Hyperlactatemia after cardiac surgery: Yes we know it is bad but can we reliably prevent and treat it?
por: Omer, Shuab
Publicado: (2020)

Hyperlactatemia in critical illness and cardiac surgery
por: O'Connor, Enda D, et al.
Publicado: (2010)

Bioinformatics: indispensable, yet hidden in plain sight?
por: Bartlett, Andrew, et al.
Publicado: (2017)

There is no place (yet) for routine administration of sildenafil to patients with ARDS
por: Cornet, Alexander D., et al.
Publicado: (2010)

The Case Against Exchange Transfusion Has Yet to Be Proved
por: Koh, Gavin C. K. W., et al.
Publicado: (2014)

Reinfection after COVID vaccination - The challenge is not yet over
por: Ahmed, Shanila, et al.
Publicado: (2021)

Safe Nanoparticles: Are We There Yet?
por: Najahi-Missaoui, Wided, et al.
Publicado: (2020)

Hyperlactatemia and altered lactate kinetics are associated with excess mortality in sepsis: A multicenter retrospective observational study
por: Rezar, Richard, et al.
Publicado: (2022)

Adrenergic signaling regulation of macrophage function: do we understand it yet?
por: Freire, Beatriz Marton, et al.
Publicado: (2022)

Why Are We Not There Yet?
por: Wenger, Nanette K.
Publicado: (2021)

Are we nearly there yet?
por: Battersby, Stephen
Publicado: (2005)

Clinical impact of intraoperative hyperlactatemia during craniotomy
por: Romano, Diana, et al.
Publicado: (2019)

Hyperlactatemia and other perioperative metabolic disturbances in neuroanesthesia
por: Klimek, Markus, et al.
Publicado: (2022)

Management of mild hidradenitis suppurativa: our greatest challenge yet
por: van der Zee, H.H., et al.
Publicado: (2021)

Should We Avoid Saline in Sepsis? It’s Probably Too Early to Definitively Conclude
por: Gueret, Gildas, et al.
Publicado: (2020)

Capillary refill time during fluid resuscitation in patients with sepsis-related hyperlactatemia at the emergency department is related to mortality
por: Lara, Barbara, et al.
Publicado: (2017)

“Nevoid Eruptive Keratoacanthoma” - Yet Another Atypical Manifestation of Generalized Keratoacanthoma
por: Sen, Sumit, et al.
Publicado: (2016)

Rising cases of meningococcal disease in Florida yet again: an urgent concern
por: Naeem, Aroma, et al.
Publicado: (2023)

Pulmonary embolism: yet another cause of hypoxaemic respiratory failure in COVID-19
por: Nieri, Dario, et al.
Publicado: (2020)

Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use
por: Hagiya, Hideharu, et al.
Publicado: (2021)

Marijuana Use as a Risk Factor for Chronic Obstructive Pulmonary Disease: Not There Yet
por: Tashkin, Donald P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kl6q8e41apipiu9qjcf0hv6hdu